Xpreza 300® Azacitidine Tablets

Xpreza 300 mg contains azacitidine and is used in the treatment of certain blood cancers and bone marrow disorders. Product listings describe its use in MDS, while oral azacitidine formulations may also be indicated for maintenance treatment of selected adults with acute myeloid leukaemia (AML).

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.